You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -239.4% | -56.9% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -0.5 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 1.6 | 0.7 |
Price / Book value | 1.4 |
Latest | Forecast | |
---|---|---|
Revenue | 138.0% | -52.8% |
PBT | 0.0% | n/a |
EPS | 0.0% | 5,249.8% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2019-12-31 | 0.72 | -9.07 | -7.55p | -22.4 | 0.0 | n/a | n/a | 0.0% |
2020-12-31 | 10.39 | -1.89 | -1.89p | -31.8 | 0.0 | n/a | n/a | 0.0% |
2021-12-31 | 1.52 | -19.91 | -10.00p | -4.3 | 0.0 | n/a | n/a | 0.0% |
2022-12-31 | 5.50 | -49.43 | -21.00p | -0.3 | 0.0 | n/a | n/a | 0.0% |
2023-12-31 | 13.09 | -32.38 | -5.00p | -1.3 | 0.0 | n/a | n/a | 0.0% |
Shield Therapeutics secures $10m investment, announces RetailBook offer Sharecast News | 06 Dec |
---|---|
Shield Therapeutics reports strong quarter for Accrufer Sharecast News | 29 Oct |
Shield Therapeutics announces promising paediatric trial results Sharecast News | 25 Sep |
RetailBook Offer | 06-Dec-24 11:31 |
---|---|
Subscription by AOP Health to raise US$10 million | 06-Dec-24 11:30 |
Business Update | 21-Nov-24 07:01 |
Q3 Trading Update | 29-Oct-24 07:01 |
Results from Phase 3 paediatric study | 25-Sep-24 07:01 |